NICE Technology Appraisals in the NHS in England (Innovation Scorecard) to December 2018Official statistics
- Publication date:
- 11 Jul 2019
- Geographic coverage:
- Geographical granularity:
- Regions, Clinical Commissioning Groups, Sustainability and Transformation Partnerships, NHS Trusts
- Date range:
- 01 Jan 2014 to 31 Dec 2018
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE).
NHS Digital has produced and published the Innovation Scorecard quarterly as an Official Statistic since January 2013 on behalf of the Office for Life Sciences. It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal (TA) recommendations.
We produce the scorecard using a range of data sources from two to five years prior to publication and no central data collection is involved.
Note: Medical Technologies are suspended pending a review of their inclusion criteria and available data sources as a result of developments by the Accelerated Access Collaborative.
Latest data to December 2018
What we measure and what we have found
73% of medicines prescribed more
6 medicine groupings used to treat major conditions
5 medicine groupings were used more
For the 12 months from January 2018 to December 2018 (compared to the previous 12 months)
Reported as Defined Daily Doses (DDD), Actual Daily Doses (ADD), mgs, vials, tablets, units, implants, pads, interventions or pens/syringes per 100,000 population or QOF register in England
Conditions covered by medicine groupings:
- Acute coronary syndrome
- Hepatitis C
- Multiple sclerosis
- Stroke (Separate medicine groupings for stroke by care setting i.e. GP and hospital)
Source: NHS Digital
electronic Prescribing Analysis and Cost Tool (ePACT) Hospital Episode Statistics (HES)